Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
110,632
-
Share change
-
+11,319
-
Total reported value
-
$1,746,095
-
Price per share
-
$2.97
-
Number of holders
-
7
-
Value change
-
+$33,415
-
Number of buys
-
2
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q2 2018
As of 30 Jun 2018,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,632 shares.
The largest 7 holders included
MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, UBS Group AG, Cornerstone Wealth Management, LLC, ROYAL BANK OF CANADA, and BREWIN DOLPHIN LTD.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.